✦ LIBER ✦

A Controlled Study of the Effects of Alendronate in a Growing Mouse Model of Osteogenesis Imperfecta

✍ Scribed by N.P. Camacho; C.L. Raggio; S.B. Doty; L. Root; V. Zraick; W.A. Ilg; T.R. Toledano; A.L. Boskey

Publisher: Springer
Year: 2001
Tongue: English
Weight: 313 KB
Volume: 69
Category: Article
ISSN: 1432-0827
DOI: 10.1007/s002230010045

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparable outcomes in fracture reductio

Comparable outcomes in fracture reduction and bone properties with RANKL inhibition and alendronate treatment in a mouse model of osteogenesis imperfecta

✍ R. Bargman; R. Posham; A. L. Boskey; E. DiCarlo; C. Raggio; N. Pleshko 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 893 KB

The effects of RANKL inhibition on fract

The effects of RANKL inhibition on fracture healing and bone strength in a mouse model of osteogenesis imperfecta

✍ Demetris Delos; Xu Yang; Benjamin F. Ricciardi; Elizabeth R. Myers; Mathias P.G. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 387 KB 👁 1 views

## Abstract Currently, the standard treatment for osteogenesis imperfecta (OI) is bisphosphonate therapy. Recent studies, however, have shown delayed healing of osteotomies in a subset of OI patients treated with such agents. The current study sought to determine the effects of another therapy, RAN

A microanalytical study of bone mineral

A microanalytical study of bone mineral in osteogenesis imperfecta

✍ JP Cassella; S Yousuf Ali 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 310 KB

A histochemical study of long bones in o

A histochemical study of long bones in osteogenesis imperfecta congenita

✍ Spencer, A. T. 📂 Article 📅 1962 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 388 KB

Osteogenesis imperfecta: A clinical stud

Osteogenesis imperfecta: A clinical study of the first ten years of life

✍ U. Vetter; B. Pontz; E. Zauner; R. E. Brenner; J. Spranger 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 535 KB

One hundred twenty-seven children with osteogenesis imperfecta (O.I.) were studied during the first 10 years of life. According to Sillence, 40 patients were assigned to type I, 39 to type III, and 48 to type IV O.I. Centiles for height, weight, and the annual number of fractures could be establishe

A fracture risk assessment model of the

A fracture risk assessment model of the femur in children with osteogenesis imperfecta (OI) during gait

✍ Jessica M. Fritz; Yabo Guan; Mei Wang; Peter A. Smith; Gerald F. Harris 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 561 KB

Osteogenesis imperfecta (OI) is a heritable bone fragility disorder characterized by skeletal deformities and increased bone fragility. There is currently no established clinical method for quantifying fracture risk in OI patients. This study begins the development of a patient-specific model for fe